Literature DB >> 6172410

Electrochemical and ESR studies on Cu(II) complexes of bleomycin and its related compounds.

K Ishizu, S Murata, K Miyoshi, Y Sugiura, T Takita, H Umezawa.   

Abstract

The 1:1 Cu(II) complexes of bleomycin (BLM) A2, BLM B2, epi-BLM B2, iso-BLM B2, depyruvamide-BLM A2, deglyco-BLM B2 and the structurally related peptides (P-5m, P-3A and P-3) have been comprehensively investigated by ESR and electrochemical methods. ESR spectra for Cu(II) complexes of BLM A2, epi-BLM B2, depyruvamide-BLM A2 and P-3 revealed the axially symmetric g-anisotropies. In contrast, ESR features of the iso-BLM B2, deglyco-BLM B2, P-5m and P-3A complexes, which lack the sixth ligation by the 3-O-carbamoyl group of mannose, exhibited rhombic g-anisotropies with decrease of the A parallel values. The cyclic voltamograms showed that all of the Cu(II) complexes underwent the well defined quasi-reversible one-electron Cu(II)/Cu(I) coupled redox reaction. The inverse of the redox potential, which measures the effective strength of the ligand field splitting, gave a linear relation with the observed g parallel value of each Cu(II) complex except for depyruvamide-BLM and P-3. The present results confirmed that the 3-O-carbamoyl group of the mannose moiety of the BLM molecule contributes to the stability of the metal site in BLM-Cu(II) complexes by ligation at the sixth coordination site.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6172410     DOI: 10.7164/antibiotics.34.994

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  2 in total

1.  Structural study of copper(I)-bleomycin.

Authors:  Teresa E Lehmann
Journal:  J Biol Inorg Chem       Date:  2004-03-10       Impact factor: 3.358

2.  X-ray crystallographic analysis of 3-(2'-phenyl-2,4'-bithiazole-4-carboxamido) propyldimethylsulphonium iodide, an analogue of the DNA-binding portion of bleomycin A2.

Authors:  R Kuroda; S Neidle; J M Riordan; T T Sakai
Journal:  Nucleic Acids Res       Date:  1982-08-11       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.